G. Walmsley Graham - 04 Jun 2024 Form 4/A - Amendment Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
Director
Signature
/s/ Graham Walmsley
Issuer symbol
OLMA
Transactions as of
04 Jun 2024
Net transactions value
-$17,448,750
Form type
4/A - Amendment
Filing time
26 Nov 2024, 16:48:49 UTC
Date Of Original Report
06 Jun 2024
Previous filing
11 Dec 2023
Next filing
11 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OLMA Common Stock Sale $10,395,000 -700,000 -50% $14.85 700,761 04 Jun 2024 See note F1
transaction OLMA Common Stock Sale $7,053,750 -475,000 -40% $14.85 708,114 04 Jun 2024 See note F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by Logos Opportunities Fund I LP ("Logos Fund I"). Logos Opportunities GP, LLC ("Logos Opportunities GP") is the general partner of Logos Fund I and the reporting person is a managing member of Logos Opportunities GP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
F2 The shares are held by Logos Opportunities Fund II LP ("Logos Fund II"). Logos Opportunities GP is the general partner of Logos Fund II and the reporting person is a managing member of Logos Opportunities GP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.

Remarks:

On June 6, 2024, the reporting person filed a Form 4 which inadvertently reported the date of the earliest transaction required to be reported as September 12, 2023. The earliest transaction required to be reported was June 4, 2024. The reporting person is filing this amendment to correct that date. None of the other information in the Form 4 is being changed by this amendment.